Frau E, Gregoire-Cassoux N, Offret M, Labetoulle M, Nodarian M, Lautier-Frau M, Offret H
Service d'Ophtalmologie, CHU de Bicêtre, Le Kremlin-Bicêtre.
J Fr Ophtalmol. 1998 Jun-Jul;21(6):409-13.
To evaluate the use of intravenous vitreous fluorophotometry in assessment of the blood-aqueous barrier in eyes with uveal melanoma.
Vitreous fluorophotometry was performed before treatment in 14 patients with uveal melanoma. Both eyes of patients were examined, and fifteen control healthy patients were examined between November 1996 and December 1996 at the department of ophthalmology of Bicêtre hospital.
Tumors with height > 6 mm and serous retinal detachments were accompanied by marked alterations of the blood-aqueous barrier, vitreous fluorophotometry showed diffusion of dye in posterior, mid and anterior vitreous: 2.99 ng/ml in the posterior vitreous and 5.20 ng/ml in the anterior vitreous. The posterior vitreous fluorescence at 60 minutes in the control eyes was 1.43 ng/ml and 1.30 ng/ml in the anterior vitreous. Diffusion of dye was present in the posterior vitreous in patients with tumor height less than 6 mm: 2.38 ng/ml (1.43 ng/ml in control eyes) at 60 minutes.
Fluorophotometry provides a method for the assessment of the blood-aqueous ocular barrier in eyes with choroidal melanoma.
评估静脉注射玻璃体荧光光度法在葡萄膜黑色素瘤患者血-房水屏障评估中的应用。
对14例葡萄膜黑色素瘤患者在治疗前进行玻璃体荧光光度法检测。对患者的双眼进行检查,并于1996年11月至1996年12月在比塞特尔医院眼科对15名健康对照者进行检查。
肿瘤高度>6mm且伴有浆液性视网膜脱离的患者血-房水屏障有明显改变,玻璃体荧光光度法显示染料在后段、中段和前段玻璃体中扩散:后段玻璃体中为2.99ng/ml,前段玻璃体中为5.20ng/ml。对照眼60分钟时后段玻璃体荧光为1.43ng/ml,前段玻璃体为1.30ng/ml。肿瘤高度小于6mm的患者后段玻璃体中有染料扩散:60分钟时为2.38ng/ml(对照眼为1.43ng/ml)。
荧光光度法为评估脉络膜黑色素瘤患者的血-房水眼屏障提供了一种方法。